Mapping of the monoclonal antibody W6/32: Sensitivity to the amino terminus of β2-microglobulin

Tissue Antigens

Volumn 51, Issue 5, 1998, Pages 567-570

  Shields, M J ^a   Ribaudo, R K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HLA; mAb; MHC; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METHIONINE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031809333     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb02994.x     Document Type: Article

References (26)

1. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978: 14: 9-20.
2. Shields MJ, Assefi NP, Hodgson W, Kim EJ, Ribaudo RK. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of B2-microglobulin. J Immunol 1998: 160: 2297-2307.
3. Bremers AJ, van der Burg SH, Kuppen PJ, Kast WM, van de Velde CJ, Melief CJ. The use of Epstein-Barr virus-transformed B lymphocyte cell lines in a peptide-reconstitution assay: identification of CEA-related HLA-A*0301-restricted potential cytotoxic T-lymphocyte epitopes. J Immunother Emphasis Tumor Immunol 1995: 18: 77-85.
4. van der Burg SH, Ras E, Drijfhout JW et al. An HLA class I peptide-binding assay-based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Hum Immunol 1995: 44: 189-198.
5. Koenig S, Woods RM, Brewah YA et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol 1993: 151: 3874-3883.
6. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 1987: 138: 1657-1659.
7. Winter CC, Carreno BM, Turner RV, Koenig S, Biddison WE. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens. J Immunol 1991: 146: 3508-3512.
8. Parham P, Brodsky FM. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 1981: 3: 277-299.
9. DiBrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol 1993: 151: 5930-5935.
10. Berger AE, Davis JE, Cresswell P. Monoclonal antibody to HLA-A3. Hybridoma 1982: 1: 87-90.
11. DiBrino M, Parker KC, Shiloach J et al. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci U S A 1993: 90: 1508-1512.
12. Horig H, Papadopoulos NJ, Vegh Z, Palmieri E, Angeletti RH, Nathenson SG. An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule. Proe Natl Acad Sci U S A 1997: 94: 13826-13831.
13. Balendiran GK, Solheim JC, Young AC, Hansen TH, Nathenson SG, Sacchettini JC. The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide. Proe Natl Acad Sci U S A 1997: 94: 6880-6885.
14. b at 2.4 Å resolution: implications for antigen-determinant selection. Cell 1994: 76: 39-50.
15. Garboczi DN, Hung DT, Wiley DC. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proe Natl Acad Sci U S A 1992: 89: 3429-3433.
16. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996: 384: 134-141.
17. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993: 75: 693-708.
18. Brodsky FM, Parham P. Monomorphic antiHLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol 1982: 128: 129-135.
19. Parham P, Barnstable CJ, Bodmer WF. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol 1979: 123: 342-349.
20. Tanabe M, Sekimata M, Ferrone S, Takiguchi M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain. J Immunol 1992: 148: 3202-3209.
21. Jefferies WA, MacPherson GG. Expression of the W6/32 HLA epitope by cells of rat. mouse, human and other species: critical dependence on the interaction of specific MHC heavy chains with human or bovine beta 2-microglobulin. Eur J Immunol 1987: 17: 1257-1263.
22. Kievits F, Ivanyi P. Monomorphic anti-HLA monoclonal antibody (W6/32) recognizes polymorphic H-2 heavy-chain determinants exposed by association with bovine or human but not murine beta 2-microglobulin. Hum Immunol 1987: 20: 115-126.
23. Mierau R, Robinson PJ, Sanderson AK, Genth E, Cramer M. Antigenic determinants shared between HLA-A, -B, -C antigens and H-2 class I molecules modified by bovine beta-2 microglobulin. Immunogenetics 1987: 26: 351-355.
24. Kahn-Perles B, Boyer C, Arnold B, Sanderson AR, Ferner P, Lemonnier FA. Acquisition of HLA class I WB/32 defined antigenic determinant by heavy chains from different species following association with bovine beta 2-microglobulin. J Immunol 1987: 138: 2190-2196.
25. Bjorkman PJ, Saper MA, Samraoui B, Bennett, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987: 329: 506-512.
26. Amzel LM, Poljak RJ. Three-dimensional structure of immunoglobulins. Annu Rev Biochem 1979: 48: 961-997.